Compositions and methods for inhibiting ribosome inactivating proteins
US12427135B2 · kind B2 · utility
0Cited by
1References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 9, 2022 |
| Grant date | Sep 30, 2025 |
| Priority date | — |
| Expiry date | Mar 9, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F5/025
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides in one aspect a method of treating, ameliorating, and/or preventing toxicity caused by a ribosome inactivating protein (RIP) in a subject. In certain embodiments, the method comprises administering to the subject a therapeutically effective amount of at least one compound of the disclosure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.